Dudediligence.

MediciNova, Inc

MNOVNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$134,599Jun ’25$123,319Sep ’25$151,739Dec ’25$186,984Mar ’26$458,439Jun ’26
Net income, by quarter
−$2.9MSep ’24−$2.8MDec ’24−$2.9MMar ’25−$3.3MJun ’25−$3.1MSep ’25$21.2MDec ’25−$2.6MMar ’26−$2.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$4.0Mnone on file$1.0Mnone on file$409,657
Operating income−$10.2M−$14.6M−$9.9M−$12.7M−$13.3M
Net income−$10.1M−$14.1M−$8.6M−$11.0M$12.0M
Operating cash flow−$9.4M−$12.9M−$7.4M−$10.6M−$9.8M
Free cash flow−$9.4M−$12.9M−$7.5M−$10.6M−$9.8M
Cash$71.4M$18.5M$51.0M$40.4M$30.8M
Shares outstanding49.0M49.0M49.0M49.0M49.2M